OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - UNITED THERAPEUTICS CORP DEL ownership

Back to all holdings Add to watchlist

UNITED THERAPEUTICS CORP DEL's ticker is and the CUSIP is 91307CAF9. A total of 23 filers reported holding UNITED THERAPEUTICS CORP DEL in Q4 2013. The put-call ratio across all filers is - and the average weighting 1.5%.

Links
Filings
Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of UNITED THERAPEUTICS CORP DEL
ValueSharesWeighting
Q4 2013$23,703,000,000
+26.7%
10,000,000
-9.1%
0.44%
+12.1%
Q3 2013$18,701,000,000
+16.8%
11,000,0000.0%0.39%
+29.7%
Q2 2013$16,006,000,000–11,000,000–0.30%–
 Download
Other shareholders

There were no reported owners of UNITED THERAPEUTICS CORP DEL in Q4 2013.

NameSharesValueWeighting ↓
View complete list of UNITED THERAPEUTICS CORP DEL shareholders